Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 312

1.

Delayed resolution of bleomycin-induced pulmonary fibrosis in absence of MMP13 (collagenase 3).

Cabrera S, Maciel M, Hernandez-Barrientos D, Calyeca J, Gaxiola M, Selman M, Pardo A.

Am J Physiol Lung Cell Mol Physiol. 2019 Feb 20. doi: 10.1152/ajplung.00455.2017. [Epub ahead of print]

PMID:
30785343
2.

Accelerated aging induced by deficiency of Zmpste24 protects old mice to develop bleomycin-induced pulmonary fibrosis.

Calyeca J, Balderas-Martínez YI, Olmos R, Jasso R, Maldonado V, Rivera Q, Selman M, Pardo A.

Aging (Albany NY). 2018 Dec 10;10(12):3881-3896. doi: 10.18632/aging.101679.

3.

Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis.

Sala MA, Balderas-Martínez YI, Buendía-Roldan I, Abdala-Valencia H, Nam K, Jain M, Bhorade S, Bharat A, Reyfman PA, Ridge KM, Pardo A, Sznajder JI, Budinger GRS, Misharin AV, Selman M.

Respir Res. 2018 Nov 26;19(1):233. doi: 10.1186/s12931-018-0932-7.

4.

Revealing Real-Life Experiences With Antifibrotic Drugs in Idiopathic Pulmonary Fibrosis.

Buendía-Roldán I, Mejía M, Selman M.

Arch Bronconeumol. 2019 Feb;55(2):73-74. doi: 10.1016/j.arbres.2018.09.018. Epub 2018 Nov 10. English, Spanish. No abstract available.

5.

Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis.

Planas-Cerezales L, Arias-Salgado EG, Buendia-Roldán I, Montes-Worboys A, López CE, Vicens-Zygmunt V, Hernaiz PL, Sanuy RL, Leiro-Fernandez V, Vilarnau EB, Llinás ES, Sargatal JD, Abellón RP, Selman M, Molina-Molina M.

Respirology. 2019 Feb;24(2):146-153. doi: 10.1111/resp.13423. Epub 2018 Oct 15.

6.

Why Does an Aging Smoker's Lung Develop Idiopathic Pulmonary Fibrosis and Not Chronic Obstructive Pulmonary Disease?

Selman M, Martinez FJ, Pardo A.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):279-285. doi: 10.1164/rccm.201806-1166PP. No abstract available.

PMID:
30211626
7.

Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.

Maldonado M, Buendía-Roldán I, Vicens-Zygmunt V, Planas L, Molina-Molina M, Selman M, Pardo A.

PLoS One. 2018 Sep 12;13(9):e0203779. doi: 10.1371/journal.pone.0203779. eCollection 2018.

8.

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendía-Roldán I, Selman M, Travis WD, Walsh S, Wilson KC; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.

PMID:
30168753
9.

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial.

Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Blahova Z, Wachtlin D, Diefenbach C, Jenkins RG.

BMJ Open Respir Res. 2018 Aug 20;5(1):e000325. doi: 10.1136/bmjresp-2018-000325. eCollection 2018.

10.

Impaired autophagic activity and ATG4B deficiency are associated with increased endoplasmic reticulum stress-induced lung injury.

Maciel M, Hernández-Barrientos D, Herrera I, Selman M, Pardo A, Cabrera S.

Aging (Albany NY). 2018 Aug 27;10(8):2098-2112. doi: 10.18632/aging.101532.

11.

Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.

Valero-Jiménez A, Zúñiga J, Cisneros J, Becerril C, Salgado A, Checa M, Buendía-Roldán I, Mendoza-Milla C, Gaxiola M, Pardo A, Selman M.

PLoS One. 2018 Mar 12;13(3):e0192963. doi: 10.1371/journal.pone.0192963. eCollection 2018.

12.

Emerging insights into the role of matrix metalloproteases as therapeutic targets in fibrosis.

Afratis NA, Selman M, Pardo A, Sagi I.

Matrix Biol. 2018 Aug;68-69:167-179. doi: 10.1016/j.matbio.2018.02.007. Epub 2018 Feb 9. Review.

PMID:
29428229
13.

Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?

Wolters PJ, Blackwell TS, Eickelberg O, Loyd JE, Kaminski N, Jenkins G, Maher TM, Molina-Molina M, Noble PW, Raghu G, Richeldi L, Schwarz MI, Selman M, Wuyts WA, Schwartz DA.

Lancet Respir Med. 2018 Feb;6(2):154-160. doi: 10.1016/S2213-2600(18)30007-9. Review.

14.

Upregulation and Nuclear Location of MMP28 in Alveolar Epithelium of Idiopathic Pulmonary Fibrosis.

Maldonado M, Salgado-Aguayo A, Herrera I, Cabrera S, Ortíz-Quintero B, Staab-Weijnitz CA, Eickelberg O, Ramírez R, Manicone AM, Selman M, Pardo A.

Am J Respir Cell Mol Biol. 2018 Jul;59(1):77-86. doi: 10.1165/rcmb.2017-0223OC.

PMID:
29373068
15.

Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.

Selman M, Ou P, Rousso C, Bergeron A, Krishnan R, Pikor L, Chen A, Keller BA, Ilkow C, Bell JC, Diallo JS.

Sci Transl Med. 2018 Jan 24;10(425). pii: eaao1613. doi: 10.1126/scitranslmed.aao1613.

PMID:
29367345
16.

R-Spondin-2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior.

Munguía-Reyes A, Balderas-Martínez YI, Becerril C, Checa M, Ramírez R, Ortiz B, Meléndez-Zajgla J, Pardo A, Selman M.

Am J Respir Cell Mol Biol. 2018 Jul;59(1):65-76. doi: 10.1165/rcmb.2017-0115OC.

PMID:
29345973
17.

The rise of interstitial lung diseases?

Pérez-Padilla R, Selman M.

Int J Tuberc Lung Dis. 2018 Jan 1;22(1):5-6. doi: 10.5588/ijtld.17.0751. No abstract available.

PMID:
29297420
18.

Corrigendum: ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis.

Lagares D, Ghassemi-Kakroodi P, Tremblay C, Santos A, Probst CK, Franklin A, Santos DM, Grasberger P, Ahluwalia N, Montesi SB, Shea BS, Black KE, Knipe R, Blati M, Baron M, Wu B, Fahmi H, Gandhi R, Pardo A, Selman M, Wu J, Pelletier JP, Martel-Pelletier J, Tager AM, Kapoor M.

Nat Med. 2017 Dec 7;23(12):1499. doi: 10.1038/nm1217-1499b.

PMID:
29216045
19.

Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.

Selman M, Rousso C, Bergeron A, Son HH, Krishnan R, El-Sayes NA, Varette O, Chen A, Le Boeuf F, Tzelepis F, Bell JC, Crans DC, Diallo JS.

Mol Ther. 2018 Jan 3;26(1):56-69. doi: 10.1016/j.ymthe.2017.10.014. Epub 2017 Oct 24.

20.

Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Mora AL, Rojas M, Pardo A, Selman M.

Nat Rev Drug Discov. 2017 Oct 30;16(11):810. doi: 10.1038/nrd.2017.225. No abstract available.

Supplemental Content

Loading ...
Support Center